MarketInOut Stock Screener Log In | Sign Up
 

Generate Biomedicines Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 08/07/2026
Generate Biomedicines Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,838.01 mln
Float60.36 mln
Earnings Date08/06/2026

1-Year Forecast

25.60
Transformational upside

Relative Strength

76 / 100
Strongly outperforming

Debt / Equity

-0.11
Negative equity

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Payout Ratio

0%
No payout

Business Description

Generate Biomedicines is a biotechnology company based in Somerville, Massachusetts, that uses machine learning to design and develop new protein-based medicines. The company is advancing several drug candidates, including treatments targeting severe asthma, cancer, and other serious conditions. Its proprietary platform combines advanced computing with laboratory technology to create therapies that would be difficult or impossible to develop using conventional methods. Founded in 2018, the company aims to push the boundaries of what modern medicine can achieve.

Key Fundamentals

EPS-2.10
RPS0.31
ROIC-141
ROA-47.89
EBITDA, mln-208
EV / EBITDA-6.73
EV / EBIT-6.33
Revenue, mln31.89
EV / Revenue43.99

Financial Strength

1-Year Target Price25.60
Short Ratio6.40
Short % of Float9.36

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.5% 56 / 100   
1 Month -8.72% 19 / 100   
2 Months 13.62% 82 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us